Systemic Lupus NCNP
Session 215
Rick Pope MPAS, PA-C, DFAAPA, CPAAPA
Western CT Medical Group Dept of Rheumatology Danbury, CT
Treatment in 2016?
• With modern therapeutic advances, the mortality rate from lupus erythematosus has decreased substantially.
• It is hoped that current research will further improve the prognosis of this disease in the near future.
South Med J. 2007 Sep;100(9):896-8. The history of lupus erythematosus.
Lupus = Latin for Wolf
Term of lupus first used in the Middle Ages to describe skin lesions that were suggestive of a wolf’s bite
1 What is this?
Lupus Types
1. Subacute Lupus Erythematosus 2. Discoid Lupus 3. Drug Induced Lupus* 4. Systemic Lupus Erythematosus 5. Neonatal Lupus*
*Will not be covered in this slide set
Speaker’s disclosures
Nothing to disclose
2 Case 1
47 y.o. African American female with “swelling all over” - Generalized joint pain - Cough with clear sputum production - Occasional pleuritic chest discomfort - Occasional dyspnea - Generalized weakness - Toe numbness - 10-11 hospitalizations with ? Tx per pt. - Rectal bleeding, N/V---Transfused
Case 1
PMHx- HTN, palpitations, COPD, blood transfusions
Surgical Hx -Partial Hyst (2003)
Meds- Norvasc, Altace, Lasix
FH- No CTD, Maternal aunt-? Arthritis
SH- Single, Last worked in 2000.
Tobacco-D/C cigs in “1980’s” X “short period of time”
ETOH- D/C age 31-32—”as much as I could get”
Case 1 ROS
Pertinent (+) Pertinent (-) Fatigue Raynaud’s ?Fever Lymphadenopathy Anorexia Seizure Sleep difficulty 2° “sore” Inflammatory eye sxs “Very light” headache Chest Pain Weak Dysphagia Occasional dry mouth and nose Sun sensitivity Dyspepsia Psoriasis Vaginal discharge Hair loss ? Left Knee rash
3 Case 1
PE- Vital signs-5’4’’, 152lbs, 130/82, 98.7 Chronically ill appearing Thinning of hair in temporal regions Mildly diminished salivary pool Diffuse abd. discomfort without guarding/rebound Diffuse synovitis, small knee effusions Hyperpigmentation—BUE, Left knee, face Generalized decreased motor strength Decrease sensation to touch in feet
Case 1
What would you do next?
Order labs: 1. CBC 2. CMP 3. Inflammatory markers 4. ANA, RF anti-CCP 5. Lyme screen 6. Urinalysis 7. Chest x-ray
Case 1
ANA (+)≥1:2560 homogeneous RF negative CBC- Mild chronic disease anemic MCI wnl WBC- 3.2 relative leukopenia, lymphopenia Platelets 97,000 CMP- Creatinine 1.3, eGFR 56ml/min ESR- 42 CRP- 28 (uln 20) Urinalysis- 1+ protein Chest x-ray- no acute process
4 Systemic lupus erythematosus: 1982 classification criteria definitions
Malar rash Fixed erythema, flat or raised, sparing the nasolabial folds
Discoid rash Raised patches, adherent keratotic scaling, follicular plugging; older lesions may cause scarring
Photosensitivity Skin rash from sunlight
Oral or nasopharyngeal Usually painless ulcers
Arthritis Nonerosive, inflammatory in two or more peripheral joints
Serositis Pleuritis or pericarditis
Systemic lupus erythematosus: 1982 classification criteria definitions
Renal disorder Persistent proteinuria or cellular casts
Neurologic disorder Seizures or psychosis
Hermatologic Hemolytic anemia, leukopenia (<4,000/mm3), lymphopenia (<1,500/mm3), or thrombocytopenia (<100,00/mm3)
Immunologic disorder Antibodies to dsDNA or SM or positive antiphospholipid antibodies (IgG or IgM antibodies, lupus anticoagulant, or false-positive serologic test positive serologic test for syphilis)
ANA test Positive
ACR Criteria for Classification of SLE
Rules for using the criteria:
A patient who exhibits any 4 of these 11 criteria is classified as having SLE
Criteria need not be present simultaneously
SLE evolves over time.
5 The 1982 criteria for classification of SLE
For the purpose of clinical studies: SLE can be diagnosed if any 4 or more of the 11 criteria are present, serially or simultaneously, during any interval of observation.
Sensitivity 96% Specificity 96% in adults and peds.
Differential diagnosis
Pt has 3 out of 4 criteria for SLE
ANA +
Leukopenia, lymphopenia, thrombocytopenia
Arthritis of two or more peripheral joints
When Is proteinuria elevated enough to consider a kidney biopsy?
1. Increasing creatinine without any other cause. (hypovolemia, medication etc) 2. Confirmed proteinuria of >1 g per 24 hours 3. Proteinuria >0.5 plus hematuria or cellular casts
Famous people with Lupus who do not have it In 2010, Lady Gaga told Larry King that she tested "borderline positive" for lupus . “But to be diagnosed with lupus, a person must have certain symptoms and a positive blood test for self-attacking antibodies”
And the pop diva told Larry she didn’t.
One in five women test positive for lupus-associated antibodies but a small fraction have the autoimmune disease.
6 Famous people with lupus
Seal The scars on the singer’s face are the result of discoid lupus erythematosus, a type of lupus involving only the skin.
Discoid Lupus
Ten percent of people with discoid lupus will go on to develop systemic lupus.
SLE: A Working Definition
1. Lupus is a systemic autoimmune disease in which the body loses tolerance to self
2. Can affect virtually any organ in the body and initial symptoms are often nonspecific, making it very difficult to diagnose
3. Typical autoantibodies seen are those reacting against nuclear components of the cell
4. Most commonly seen in women of childbearing age but 10% of patients are men
5. Lupus is a clinical diagnosis made by a clinician. Most patients will have four or more ACR criteria.
Systemic Lupus Erythematosus SLE Definition/Diagnosis • Prototype of auto-immune disease • Onset maybe acute, episodic, or insidious • Anything can happen to any organ system at any time. • Antinuclear antibodies are almost always present • Serositis & Immune complexes can be the hallmark and pathogenesis of the disease.
7
SLE: Average Time to Diagnosis
• Average time of two years between initial symptomatology and definitive diagnosis¹.
1.Cervera, Medicine, 1993; Font, Semin Arthritis Rheum, 2004
The 1982 revised criteria for classification of SLE Revised 1997
1.Malar rash 6. Serositis 2.Discoid rash 7. Renal disorder 3.Photosensitivity 8. Neurologic disorder 4.Oral ulcers 9. Hematologic disorder 5.Arthritis 10. Immunologic disorder 11. Antinuclear antibody
Revised 1997
Malar Rash
1. Photosensitive 2. Spares nasolabial folds 3. Rosacea does not spare nasolabial folds*
8 Malar Rash
• Fixed erythema, flat or raised, over malar eminences
• Tends to spare nasolabial folds
Malar Rash
Erythematous May be hyperpigmented in darker skinned individuals Flat or raised May occur on exposure to sunlight SPARES NASOLABIAL FOLDS
Malar Rash Pathognomic
9 Differential Diagnosis of Malar Rash
Malar rash, flushing or hyperpigmentation of bilateral cheeks and bridge of nose which spares the nasolabial folds, is pathognomic of lupus.
Nevertheless, similar rashes may be present in a variety of other disorders including:
• Rosacea • Glucocorticoid-induced atrophy • Dermatitis • Chloasma/ Melasma • Seborrheic • Benign flushing • Atopic • Contact
Skin and mucosal lesion Patterns
1. Acute - localized or generalized
2. Subacute – Annular or psoriaform
3. Chronic – Discoid localized or generalized
4. Nonspecific rashes (biopsy can be helpful and diagnostic)
• vasculitis • alopecia • livedo reticularis • Raynaud’s • urticaria • lichen planus
Lupus Vasculitis
10 Lupus Alopecia
• Most SLE patients • Localized or generalized • Scalp, eyebrows, eyelashes, body hair • Increased with disease activity
Subsides as disease subsides
Livedo Reticularis
Raynaud’s Phenomenon
• Vascular • Color Changes • Ulcers • Gangrene
11 Urticaria
Lichen Planus
The 1982 revised criteria for classification of SLE
1.Malar rash 6. Serositis 2.Discoid rash 7. Renal disorder 3.Photosensitivity 8. Neurologic disorder 4.Oral ulcers 9. Hematologic disorder 5.Arthritis 10. Immunologic disorder 11. Antinuclear antibody
Revised 1997
12 Discoid Lupus Erythematosis (DLE) Subset
• Patients with DLE have a 5 to 10% risk of developing SLE
90-95% do not go on to SLE
• This form of SLE tends to be mild
• The more numerous and widespread the lesions are the higher the risk of developing SLE
Discoid Lupus
Can occur in 25% of SLE patients
Discoid Rash
Erythematous raised patches Adherent keratotic scale Follicular plugging
Atrophic scarring may occur as DLE on arm lesions age
LOOK IN EARS! DLE on arm DLE in ear
DLE in ear
13 Discoid Rash
• Erythematous raised patches with adherent keratotic scaling and follicular plugging
• Atrophic scarring may occur in older lesions
Subacute Cutaneous Lupus Subset of (SCLE)
•Positive anti–Ro (SS-A) and anti–La (SS-B) •Photosensitive •Face usually spared •Non scarring •Fatigue common •Arthralgia and arthritis
•50% of patients with SCLE will have SLE
THE 1982 REVISED CRITERIA FOR CLASSIFICATION OF SLE
1.Malar rash 6. Serositis 2.Discoid rash 7. Renal disorder 3.Photosensitivity 8. Neurologic disorder 4.Oral ulcers 9. Hematologic disorder 5.Arthritis 10. Immunologic disorder 11. Antinuclear antibody
Revised 1997
14 Photosensitivity
• Skin rash as an unusual reaction to sunlight
• By patient history or practitioner observation
This is not easily sun burned Or getting blisters with a 2° sunburn
The 1982 revised criteria for classification of SLE
1.Malar rash 6. Serositis 2.Discoid rash 7. Renal disorder 3.Photosensitivity 8. Neurologic disorder 4.Oral ulcers 9. Hematologic disorder 5.Arthritis 10. Immunologic disorder 11. Antinuclear antibody
Revised 1997
Mucocutaneous Ulcers
• Oral or nasopharyngeal ulcerations
• Must be observed by physician health care provider
• Often painless
15 The 1982 Revised Criteria For Classification of SLE
1.Malar rash 6. Serositis 2.Discoid rash 7. Renal disorder 3.Photosensitivity 8. Neurologic disorder 4.Oral ulcers 9. Hematologic disorder 5.Arthritis 10. Immunologic disorder 11. Antinuclear antibody
Revised 1997
Arthritis
1. Nonerosive arthritis involving 2 or more peripheral joints
2. Characterized by tenderness swelling, or joint effusion.
Jaccoud’s Arthropathy
Reducible deformities No erosions Peri-articular fibrosis and ligamentous laxity Swan neck deformities
16 Rhupus
• Erosive and symmetric pattern
• Associated erosive pattern on x-ray
• 65% have a positive RF and anti-CCP -
THE 1982 REVISED CRITERIA FOR CLASSIFICATION OF SLE
1.Malar rash 6. Serositis 2.Discoid rash 7. Renal disorder 3.Photosensitivity 8. Neurologic disorder 4.Oral ulcers 9. Hematologic disorder 5.Arthritis 10. Immunologic disorder 11. Antinuclear antibody
Revised 1997
Serositis
Pleuritis - convincing history of pleuritic pain or rub heard by a physician/pratitioner or evidence of pleural effusion.
or
Pericarditis - documented by ECG or rub or evidence of pericardial effusion. Transthoracic echo, transesophageal echo.
17 SLE Pleuropulmonary disease
• Pleuritis/Pleural effusion • Infiltrates/Atelectasis • Acute lupus pneumonitis • Pulmonary hemorrhage • “Shrinking lung” - diaphragm dysfunction • Subclinical restrictive disease
Left sided pleural effusion in SLE
SLE Cardiac involvement
• Pericarditis • Myocarditis • Endocarditis, Libman-Sacks* • Accelerated atherosclerosis
*Described as non infectious cross between bacterial endocarditis and fibroid non-infectious growth on cardiac valves. Described in 1928 by Libman and Sacks in the American Journal of Pathology and associated with similar lesions in kidney and rash on face.
18 THE 1982 REVISED CRITERIA FOR CLASSIFICATION OF SLE
1.Malar rash 6. Serositis 2.Discoid rash 7. Renal disorder 3.Photosensitivity 8. Neurologic disorder 4.Oral ulcers 9. Hematologic disorder 5.Arthritis 10. Immunologic disorder 11. Antinuclear antibody
Revised 1997
Renal Disorder 1. Persistent proteinuria greater than 0.5 grams/ 24 hr or greater than 3+ if quantitation not performed
or
Red cell cast 2. Active urinary sediment - Cellular casts - may be red cell, hemoglobin, granular, tubular, or mixed.
SLE Renal involvement
• Usually asymptomatic (Pearl: get UA) • Gross hematuria • Nephrotic syndrome • Acute renal failure • Hypertension • End stage renal failure
19 SLE Nephritis
Nephritis remains the most frequent cause of disease-related death.
THE 1982 REVISED CRITERIA FOR CLASSIFICATION OF SLE
1.Malar rash 6. Serositis 2.Discoid rash 7. Renal disorder 3.Photosensitivity 8. Neurologic disorder 4.Oral ulcers 9. Hematologic disorder 5.Arthritis 10. Immunologic disorder 11. Antinuclear antibody
Revised 1997
Neurologic disorder Psychiatric disorder
1. Seizures - in the absence of offending drugs or known metabolic derangements, e.g., uremia, ketoacidosis, or electrolyte imbalance
or
2. Psychosis - in the absence of offending drugs or known metabolic derangements, e.g. uremia, ketoacidosis, or electrolyte imbalance
20 THE 1982 REVISED CRITERIA FOR CLASSIFICATION OF SLE
1.Malar rash 6. Serositis 2.Discoid rash 7. Renal disorder 3.Photosensitivity 8. Neurologic disorder 4.Oral ulcers 9. Hematologic disorder 5.Arthritis 10. Immunologic disorder 11. Antinuclear antibody
Revised 1997
Thrombocytopenic Purpura
• Non blanching • Purplish discoloration • Purpura is not a disease but indicates underlying bleeding disorder • Usually lower extremities • < 1 cm is petechiae
Hematologic Disorder
Hemolytic anemia with reticulocytosis OR Leukopenia—less than 4000/mm 3 total on two separate occasions OR Lymphopenia—less than 1500/m 3 on two or more occasions OR Thrombocytopenia—less than 100,000/m³ in the absence of offending drugs
21 THE 1982 REVISED CRITERIA FOR CLASSIFICATION OF SLE
1.Malar rash 6. Serositis 2.Discoid rash 7. Renal disorder 3.Photosensitivity 8. Neurologic disorder 4.Oral ulcers 9. Hematologic disorder 5.Arthritis 10. Immunologic disorder 11. Antinuclear antibody
Revised 1997
Immunologic Disorder “ANA subsets or ENAs”
1. Anti-dsDNA: antibody to native DNA in abnormal titer or
2. Anti-Sm: presence of antibody to Sm nuclear antigen or
3. Antiphospholipid antibodies by positive IgG or IgM anticardiolipin antibodies (not IgA) or a positive test for lupus anticoagulant, or a false positive test for syphilis (RPR) for 6 months
Immunologic Disorder
3. Antiphospholipid antibodies:
• Anti-ACL by + antibodies
• Lupus anticoagulant +
• False positive test for syphilis RPR for 6 months (Not VDRL)
22 SLE Laboratories
• Antibodies to dsDNA are present in 70% of lupus patients and are >95% specific for lupus • Anti-Sm (Smith) + in up to 30% of lupus patients and is pathognomonic • Decreased C3 and C4 indicate activity • Anti-Ro (SS-A) congenital heart block (refer children of mothers for pediatric evaluation)
THE 1982 REVISED CRITERIA FOR CLASSIFICATION OF SLE
1.Malar rash 6. Serositis 2.Discoid rash 7. Renal disorder 3.Photosensitivity 8. Neurologic disorder 4.Oral ulcers 9. Hematologic disorder 5.Arthritis 10. Immunologic disorder 11. Antinuclear antibody
Revised 1997
Antinuclear Antibody
1:20 - 1:40 Screening titer is + in most labs: 1: x titer Higher titers Speckled Rim/peripheral likelihood of disease At any point in time (example 1:320, 640,1280, 2560)
Patterns
• Speckled • Rim/peripheral • Homogeneous/Diffuse • Nucleolar
Courtesy ACR slide collection Nucleolar Diffuse/homogeneous
23 Antinuclear Antibodies ANA
•Low titer positive ANA in normal population increases with age
•Patterns of ANA immunofluorescence vary.
-SLE is commonly associated with peripheral or speckled patterns
-Homogeneous patterns are associated with drug induced lupus.
-First degree relatives of patients with SLE are likely to be ANA positive
32% of relatives had antinuclear antibodies, compared with 1.5% of the healthy controls
(Sack, Primer 2001; Van der Linden, J Rheumatol 2001)
+ANA What does it mean
• Sensitivity 95-98%
• Specificity very low
• Positive in many autoimmune diseases
• 10 to 35% of adults aged >65 have + ANAs and do not have Lupus or other autoimmune disease
• Negative ANA occurs in less then 3% of lupus patients
ANAs
1. ANAs do not correlate with disease activity.
2. Do not forget other causes of a positive ANA.
3. A patient with a negative ANA has less than a 3% chance of developing SLE.
24 Other causes positive ANA
Other Collagen Vascular Diseases
• RA, Sjogren’s, Scleroderma, Myositis • Infections (viral, bacterial, spirochetal) • Thyroiditis or Graves • Cancers such as melanoma, breast, lung • GI ( hepatitis, UC, Crohn’s, Primary Biliary Cirrhosis • Lung (pulmonary fibrosis, TB) • Medications
Diagnostic Imaging
• Not valuable for diagnosis of lupus
• Used in detecting specific organ manifestations and in ruling out other disorders.
Diagnostic Imaging
X-ray -Distinguish erosive or deforming arthritis -Check for cardiopulmonary involvement (cardiomegaly, interstitial lung disease, pleural effusion)
Echocardiogram -Identify pericardial effusion -Identify pulmonary hypertension
Pulmonary function test: -Useful for picking up low diffusion capacity (DLCO), suspicious for pulmonary hypertension -Identify restrictive versus obstructive disease
25 SLE
Common manifestations ACR Criteria
1. Arthritis 83% 2. Malar rash 54% 3. Photosensitivity 41% 4. Nephropathy 34% 5. Oral Ulcers 30% 6. Serositis 28% 7. Seizure/Psychosis 12%
Font, Semin Arthritis Rheum 2004 © 2008 American College of Rheumatology
SLE Common manifestations not part of ACR criteria
1. Fever and Constitutional Symptoms 42% 2. Raynaud's Phenomenon 22% 3. Alopecia 18% 4. Cutaneous Vasculitis 13%
Font, Semin Arthritis Rheum 2004 © 2008 American College of Rheumatology
Clustering of symptoms
1. Cutaneous, articular and renal manifestations tend to appear “together”
2. CNS thrombotic and muscular symptoms also cluster, although to a lesser extent
Font, Semin Arthritis Rheum2004 © 2008 American College of Rheumatology
26 Case 2
• 33 year old Caucasian female is referred for + ANA speckled pattern with + dsDNA. • CC: recent onset of arthritis symptoms in the index finger of the left hand for the past eight months and she describes a sausage shaped swelling making it difficult to make a fist. These symptoms dissipated and then the long finger developed the same symptoms. She also has Raynaud’s phenomenon but denies other symptoms of connective tissue disease. She does complain of Raynaud’s in the cold months of the year
• PMHx: History of cholecystectomy for chronic nausea, MVA in 2004 and 2010 left with recurrent low back pain
Case 2
• PMHx continued:
• 3 episodes of renal stones • ADD Rx with Vyvanse • Depression- Rx on Zoloft
• FMHx: Grandmother has SLE and “arthritis”
Differential Diagnosis of Lupus
• SLE has been termed “the great imitator” for its propensity to mimic various other disorders. • Differential diagnoses to consider when a patient presents with polyarticular joint pain.
• Early Rheumatoid Arthritis • Mixed Connective Tissue Disease- Undifferentiated Connective Tissue Disease • Anti phospholipid antibody syndrome (APLS) • Fibromyalgia with positive ANA • Primary Sjogren’s Syndrome • Vasculitis • Scleroderma • Drug induced lupus
27 Did she meet the SLE criteria?
1. She has ANA and dsDNA 2, She has arthritis
• She has Raynaud’s (not a criteria)
• The answer is no but we treated her as if she has SLE
Case 2
• Chest x-ray was negative • Urinalysis was negative for protein • No hypertension, no hyperlipidemia • HIV and Hep studies were negative. • Child bearing years and worked up for APLS (LAC and cardiolipins were -)
Case 2
• What is the best approach in SLE patients with arthritis who have no internal organ involvement?
• 1st line NSAIDS COX 2s preferred
• Anti-malarials low dose-200mg BID of hydroxychloroquine with benefit of decreased flares and of developing end organ damage
28 Management Goals for SLE for co-management with PCP
• Counseling, education
• Decrease inflammation; prevent end-organ injury/failure
• Provide HBP Rx
• Evaluate for dyslipidemia
• Maintain up-to-date immunizations
Management Goals for SLE for co-management with PCP
• Management of infection
• Identify patients at risk of thrombo- occlusive events
• Family planning/contraceptive issues
• If pregnant refer to maternal/fetal specialist or high risk OB-GYN
Take home points
• Lupus is treatable • Most patients it is an annoyance because they take medication and see the rheumatologist and PCP more often • Educate your patient on maintaining controlled BP and lipids • Vaccinate your patients for infection • Monitor for changes and look for any new symptoms
29 Summary
• Do not order ANAs for broken bones
• Most ANAs do not mean Lupus
• Know what you are going to do with the result of an ordered lab test.
• Lupus patients can live and accomplish goals just like everyone else
Questions? Thank you
Rick Pope MPAS, PA-C, DFAAPA [email protected]
Extra Slides
30 Differential Diagnosis of Fever
Low grade fever is a systemic sign of infection or inflammation. Common diagnoses to consider include: • InfectionTuberculosis, -Malaria, AIDS-associated infections • Malignancy -lymphoma • Drug-induced • Inflammatory and Collagen-vascular disease -Sarcoidosis, SLE, Stills disease, Vasculitis
(Bor DH. Approach to patient with FUO. Up to Date v.14.2 )
Photosensitivity
Pathophysiology Clinical Correlation
• UV light damage 29 lupus patients (Finland)
• Disease activity increased significantly
• epidermal/dermal cells apoptosis in spring and summer
• nuclear autoantigen exposed • Most due to renal disease, low
complements, hematologic • immune system sensitized Flares in “photosensitive” patients • autoantibodies production and in “not-photosensitive” pts
No difference in sun-avoidant behaviors or sun protection use between “photosensitive” pts and malar rash multiorgan flares “not-photosensitive” pts
(Hansen, Ann Rheum Dis2004) Navratil, Rheum Dis Clin North Am 2004 © 2008 American College of Rheumatology
WORLD HEALTH ORGANIZATION CLASSIFICATION OF LUPUS NEPHRITIS
Class I Normal Class II Mesangial IIA Minimal alteration IIB Mesangial glomerulitis Class III Focal and segmental proliferative glomerulonephritis Class IV Diffuse proliferative glomerulonephritis Class V Membranous glomerulonephritis Class VI Glomerular sclerosis
31 ACR Criteria for Classification of SLE
• Initially published in 1971
Purpose: to provide a standardized definition of SLE for use in research
• Revised in 1982
• Clarifications made in 1997
Revised the immunologic criteria to reflect the growing knowledge and new diagnostic tests available
Criteria as detailed on the following slides are listed almost verbatim from the Primer on Rheumatic Diseases. Original sources: (Tan, 1982; Hochberg, 1997)
32